₹ 426 - ₹ 448
21-Dec-2023 - 26-Dec-2023
₹ 14784.00



21-Dec-2023 - 26-Dec-2023

₹ 426 - ₹ 448

Price Band

₹ 14784.00

Minimum Investment


Bid Lot


  • Face Value - ₹ 10/- Per Share

  • Listing at NSE,BSE

  • 134,943 Application Required in Retail for 1 Time.

  • Registrar : KFin Technologies Limited

IPO Details

Fresh Issue of Equity Shares aggregating upto ?320 Crore and Offer for Sale of 5,580,357 Equity Shares

Category % Shares/Amount
QIB 50% 6,361,606 Shares Rs. 285 Cr
HNI 1 5% 636,161 Shares Rs. 28.50 Cr @ 1377 forms 1 X
HNI 2 10% 1,272,322 Shares Rs. 57 Cr @ 2754 forms for 1 X
Retail 35% 4,453,125 Shares Rs. 199.50 Cr @ 134943 forms for 1 X

BRLMs: ICICI Securities, JM Financial

Application Require for 1 Time

Retail (Upto 2 Lakh) HNI (2 Lakh to 10 Lakh) HNI (Above 10 Lakh)
134943 forms for 1 X 1377 forms 1 X 2754 forms for 1 X

IPO Lot Size

Category Lots Shares Amount
Retail (Upto 2 Lakh) 1 33 ₹ 14,784
Retail (Upto 2 Lakh) 13 429 ₹ 192,192
S-HNI (2 Lakh to 10 Lakh) 14 462 ₹ 206,976
S-HNI (2 Lakh to 10 Lakh) 67 2211 ₹ 990,528
B-HNI (Above 10 Lakh) 68 2244 ₹ 1,005,312

IPO Timeline

  • Open Date

  • Close Date

  • Basis of Allotment Date

  • Initiation of Refunds

  • Credit Shares to Demat A/c

  • IPO Listing Date


Subscription as on
26-Dec-2023 14:34

Category Book Size Subscription No. of Times
QIB 2,544,643 ₹ 114.00 Cr. 44,063,514 ₹ 1974.05 Cr. 17.32x
HNI (<10 LAKH) 636,161 ₹ 28.50 Cr. 10,085,097 ₹ 451.81 Cr. 15.85x
HNI2 (>10 LAKH) 1,272,322 ₹ 57.00 Cr. 20,875,965 ₹ 935.24 Cr. 16.41x
RETAIL 4,453,125 ₹ 199.50 Cr. 32,457,051 ₹ 1454.08 Cr. 7.29x
Total 8,906,251 107,481,627 12.07x
Category Book Size Subscription No. of Times
QIB 2,544,643 ₹ 114.00 Cr. 44,063,514 ₹ 1974.05 Cr. 17.32x
HNI (<10 LAKH) 636,161 ₹ 28.50 Cr. 10,085,097 ₹ 451.81 Cr. 15.85x
HNI2 (>10 LAKH) 1,272,322 ₹ 57.00 Cr. 20,875,965 ₹ 935.24 Cr. 16.41x
RETAIL 4,453,125 ₹ 199.50 Cr. 32,457,051 ₹ 1454.08 Cr. 7.29x
Total 8,906,251 107,481,627 12.07x

*Excluding Anchor

Total No. of Application Approx : ~819700 (6.07 Appwise)

Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.

About Company

  • Innova Captab Limited (“Innova Captab”) was incorporated on January 3, 2005. Innova Captab is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports. Their business includes (i) a contract development and manufacturing organization (“CDMO”) business providing manufacturing services to Indian pharmaceutical companies, (ii) a domestic branded generics business and (iii) an international branded generics business.
  • In Fiscal 2022, among Indian formulation CDMO players considered in the CRISIL Report, they recorded the 3rd highest operating revenue, the 2nd highest operating profit margin, the 3rd highest net profit margin and the 2nd highest return on capital employed.
  • Company’s comprehensive CDMO formulation capabilities allow them to offer their customers multiple dosage forms, including oral solids, oral liquids, dry syrups and injectables, as well as more complex delivery forms such as modified and sustained release forms and tablets in capsules. They also have added products using new technologies like nano technology.
  • In Fiscal 2023 and in the 3 months ended June 30, 2023, they had 182 and 133 CDMO customers, respectively.
  • In Fiscal 2023 and in the 3 months ended June 30, 2023, they manufactured a diverse generics product portfolio of over 600 products and market them under their own brands in the Indian market through a developed network of approximately 5,000 distributors and stockists and over 150,000 retail pharmacies.
  • In addition, during Fiscal 2023 and the 3 months ended June 30, 2023, they exported branded generic products to 20 and 16 countries, respectively.
  • Innova Captab has 2 manufacturing facilities in Baddi, Himachal Pradesh. They were ranked 3rd among their peers in terms of their finished tablet and capsule manufacturing capacity in India. They have a dedicated R&D laboratory and pilot equipment located at their manufacturing facility in Baddi. In addition, they are looking to establish a new R&D centre in Panchkula, Haryana.
  • The company acquired Sharon pursuant to CIRP under the IBC and infused ?195.40 crore into Sharon on June 26, 2023.
Read More


  • Leading presence and one of the fastest growing CDMOs in the Indian pharmaceutical formulations market
  • Well established relationships with the marquee CDMO customer base
  • Highly efficient operations, including the world class manufacturing facilities and supply chain
  • Rapidly growing domestic and international export branded generics businesses
  • Strong R&D focus to build an increasingly complex product portfolio and attract and retain customers
  • Consistent financial performance
  • Experienced promoters and management team

Company Promoters

Manoj Kumar Lohariwala and Vinay Kumar Lohariwala are the promoters of the company.

Company Financials

Innova Captab Limited's revenue increased by 16.45% and profit after tax (PAT) rose by 6.26% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended 30 Jun 2023 31 Mar 2023 31 Mar 2022 31 Mar 2021
Assets 1,086.16 704.41 575.48 369.62
Revenue 234.37 935.58 803.41 412.03
Profit After Tax 17.59 67.95 63.95 34.50
Net Worth 294.27 276.46 208.56 144.78
Reserves and Surplus 317.51 228.51 196.61 132.82
Total Borrowing 441.90 235.19 198.18 45.03
Amount in ? Crore


Objects of the Issue

  • Repayment and / or prepayment, in part or in full, of certain outstanding loans of the company
  • Investment in the Subsidiary, UML, for repayment and / or prepayment in part or full of outstanding loans availed by UML
  • Funding the working capital requirements
  • General Corporate Purposes

How to Apply

Apply for IPO in few simple steps.

  • Step 01 :

    Once you create your account, Login to InvestoYard.

  • Step 02 :

    Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.

  • Step 03 :

    Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).

  • Step 04 :

    Enter your UPI ID and you will receive mandate on your UPI App.

  • Step 05 :

    Once you accept the mandate, Application is submitted successful.

  • Applying for an IPO is easier than ever with InvestoYard, in just a few clicks your application is processed. You can bid for any IPO through InvestoYard, the bidding process is simple and hassle free. Every company has a lot size decided & you can buy in multiples of the decided lot.
  • If lot size is 15, then you have to bid for multiples of 15 share like 30,45,60 and so on.
  • The maximum subscription amount for retail investors is 2 lakh.
  • Any bid can be at a desired price or cut off price given by the company.

  • Enter the number of shares you wish to buy, as per the lot size.
  • You can apply at the cut off price set by the company or bid for a desired amount within the price band.
  • Maximum three bids will be accepted.
  • You then need to enter the UPI ID on InvestoYard’s IPO application form.

  • You will immediately get a fund blocked request on your UPI for the submitted IPO application.
  • The funds will be blocked in your bank account until allotment when it is debited.
  • The limit for IPO application is Rs 2 lakh per transaction on UPI.
  • On allotment of the shares, the money will be automatically debited.
  • If the share aren’t allotted the blocked funds will reflect back into your account.

Frequently Asked Questions

Check Allotment